Results
eNauka >
Results >
Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE study
| Title: | Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE study | Authors  : | Nabors, Louis Burt; ...; Grujicic, Danica M; ...; (broj, koautora 17) | Issue Date: | 2015 | Publication: | NEURO-ONCOLOGY | ISSN: | 1522-8517 Neuro-oncology Search Idenfier |
Type: | Article | Collation: | vol. 17 br. 5 str. 708-717 | DOI: | 10.1093/neuonc/nou356 | WoS-ID: | 000356263100011 | Scopus-ID: | 2-s2.0-84928882474 | PMID: | 25762461 | PMCID: | PMC4482861 | URI: | https://enauka.gov.rs/handle/123456789/807063 | Project: | Merck KGaA, Darmstadt, Germany | Metadata source: | (Preuzeto iz Nasi u WoS) | M-category: | 21a+M21a+ |
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.